Back to contract actions
PIIDW81K0025CA008DEFINITIVE CONTRACT
ABBOTT MOLECULAR INC.
UEI: NK5QDVJBHMN7
$1,521,794.33
of $5,804,821 ceiling2 offersFirm fixed price
Awarding Agency
Sub-Agency
Department of the Army
Start Date
October 1, 2026
End Date
September 30, 2026
NAICS
PSC
6505
Value & period
Obligated to date
$1,239,477
Ceiling (base + all options)
$5,804,821
Base + exercised options
$2,761,265
Unexercised options
$3,043,555
Pricing
Firm fixed price
Date signed
June 27, 2025
Current end
September 30, 2027
Potential end (all options)
September 30, 2029
Commercial item
Commercial products/services
Subcontracting plan
Plan not included - no subcontracting possibilities
Multi-year
No
Consolidated
Not consolidated
Competition
Extent competed
Competed under SAP
Offers received
2
Solicitation procedures
Simplified acquisition
Set-aside
No set aside used.
Solicitation ID
Posted on SAM.gov
Yes
Agencies & offices
Awarding office
W40M MRC0 WEST
Funding agency
Department of Defense
Funding sub-agency
Defense Health Agency
Funding office
AMC BAMC FSH - MM
Recipient
Address
1300 E TOUHY AVE, DES PLAINES, IL 60018
County
COOK
Congressional district
IL-08
Business categories (at award)
Manufacturer of GoodsNot Designated a Small BusinessU.S.-Owned BusinessPlace of performance
City
SAN ANTONIO
County
BEXAR
State
TEXAS
ZIP
78234
Congressional district
TX-21
Classification
NAICS
- 32 Manufacturing
- 3254 Pharmaceutical and Medicine Manufacturing
- 325413 In-Vitro Diagnostic Substance Manufacturing
PSC
- 65 Medical/dental/veterinary eqpt/supp
- 6505 Drugs and biologicals
Transactions (6)
| Date | Mod # | Obligation |
|---|---|---|
| Jun 27, 2025 | 0 | +$0 |
| Dec 3, 2025 | P00001 | +$1,521,794 |
| Feb 2, 2026 | P00002 | +$0 |
| May 28, 2026 | P00003 | -$315,848 |
| Jun 15, 2026 | P00004 | +$33,531 |
| Jun 30, 2026 | P00005 | +$0 |